Mr. James Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) EXTENDS THE LETTER OF INTENT WITH DR. DALE STEVENS, PH.D., DEPARTMENT OF PSYCHOLOGY, FACULTY OF HEALTH, YORK UNIVERSITY

Pursuant to terms and conditions of the letter of intent (LOI) dated Nov. 10, 2023, Ndatalyze Corp. and the parties have agreed to an extension to Jan. 15, 2024. This extension was necessary to accommodate York University's internal review processes and is not expected to affect the clinical study. A draft of the Mitacs project application has been prepared and is currently under review.

The corporation also announces that the DNA data gathering protocols and preliminary DNA scoring routines have been developed. The YMI interface has been modified for the clinical study requirements and DNA-associated biometric data gathering is expected to begin before Dec. 20, 2023.

About YMI

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time, and applies this knowledge toward a fuller understanding of how mental health develops and to improve mental well-being. YMI combines machine-learning with a proprietary reference database that contains greater than 1,200 person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle to generate a personalized graphic report predicting an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

We seek Safe Harbor.